BIONEXUS GENE LAB CORP

Go to BIONEXUS GENE LAB CORP Website

$5.61

-1.03 (-15.51%)
Live
Previous Close

$6.64

Day Range

$5.55 - $6.64

Previous Day Range

$6.08 - $6.78

Market Cap

$11.6 million USD

Day Vol.

149859

Previous Day Vol.

159598

Currency

USD

Primary Exchange

None

BioNexus Gene Lab Corp, through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. Th...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

BioNexus Gene Lab Corp. (BGLC) filed its 2024 annual report, showcasing strategic realignment, technological advancement, and improved financial performance. The company highlighted its blockchain-native treasury strategy, expansion of genomic diagnostics offerings, and partnerships to scale its AI-based health diagnostics initiatives.

Related tickers: BGLC.

Read Full Article

KUALA LUMPUR, Malaysia, April 20, 2024 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corporation (NASDAQ: BGLC), peneraju global dalam diagnostik genomik dan teknologi penjagaan kesihatan, mengumumkan pelaburan strategik melalui anak syarikat milik penuh mereka, MRNA Scientific Sdn Bhd, dalam Ascension Innovation Sdn Bhd (AISB), sebuah syarikat persendirian di Malaysia. Pelaburan ini menegaskan komitmen BGLC dalam memajukan penyelesaian penjagaan kesihatan menerusi AI dan analisis ramalan termaju.

Related tickers: BGLC.

Read Full Article
Trending Tickers

Please sign in to view